Please login to the form below

Not currently logged in
Email:
Password:

ABPI names Amgen’s UK head as president

John Kearney replaces Pfizer’s Jonathan Emms

John Kearney, ABPIThe Association of the British Pharmaceutical Industry (ABPI) has appointed John Kearney as its new president, effective from April 24.

Kearney has over 35 years of experience in the pharma industry and currently holds the position of general manager UK and Ireland at Amgen.

He replaces Jonathan Emms, who is stepping down as president as he is leaving his role as head of Pfizer's UK business to a new role with the company in the US.

Commenting on his appointment, Kearney said: “I am delighted to be building on the recent leadership of Jonathan Emms, at a time when the pharmaceutical industry as a whole is delivering such a high quality and quantity of new science and treatment innovations.

“I look forward to playing my part in ensuring those innovations are able to make a real difference in the funding and provision of health services, in the outstanding work of healthcare professionals in the UK, and – ultimately – to patients.”

Kearney held UK and international roles at GlaxoSmithKline and international roles at Pfizer, before joining Amgen in 2007. He has been on the board of the ABPI since 2008 where he has worked on a number of key initiatives, including leading its pricing team in negotiations with the Department of Health to secure the 2014 PPRS.

Stephen Whitehead, CEO of the ABPI, added: “I am delighted to be working alongside John as president. His unique experience and expertise across the industry will be crucial as he leads the ABPI and the UK pharmaceutical industry through the opportunities and challenges in 2015.”

10th February 2015

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics